Molecular Partners AG ADR (MOLN) — Cash Flow Reinvestment Rate
Molecular Partners AG ADR (MOLN) has a Cash Flow Reinvestment Rate of 0.57x as of March 2022, reinvesting $93.61 Million (capex $380.00K plus investments $-93.23 Million) from operating cash flow of $163.56 Million. Check MOLN cash flow quality index to evaluate the quality of earnings relative to operating cash generation.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Molecular Partners AG ADR Cash Flow Reinvestment Rate (2015–2022)
Historical reinvestment intensity for Molecular Partners AG ADR across 2 annual periods. Explore Molecular Partners AG ADR (MOLN) cash flow to debt to assess how comfortably operating cash covers total debt obligations.
Annual Cash Flow Reinvestment Rate for Molecular Partners AG ADR (2015–2022)
Year-by-year capital reinvestment analysis for Molecular Partners AG ADR. For live market cap and broader valuation context, see Molecular Partners AG ADR (MOLN) total market value.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2022 | 0.86x | $102.54 Million | $118.57 Million | $1.42 Million | ▲ +1551.2% |
| 2015 | 0.05x | $1.39 Million | $26.50 Million | $1.39 Million | — |